A multicenter randomized trial to study silodosin versus naftopidil for the treatment of benign prostatic hyperplasia.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2015
At a glance
- Drugs Naftopidil (Primary) ; Silodosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 19 Sep 2015 New trial record